576.23USD+1.37%Mkt Cap: 24.50B USDP/E: 21.33Last update: 2026-05-26
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationa…
Industry Peers
Drug Manufacturers - Specialty & Generic152.45BSEKP/E 166.3
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
33.63BPLNP/E 21.9
18.90BUSD—
15.76BUSDP/E 24.1
13.30BEURP/E 30.3
12.92BSEKP/E 39.1
Indicators:|
Key Statistics
Company
Market Cap24.50B USD
Enterprise Value21.87B USD
Revenue (TTM)3.17B USD
Gross Profit2.80B USD
Net Income (TTM)1.33B USD
Revenue/Share72.12 USD
Last Price576.23 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS91307C1027
Valuation
P/E (Trailing)21.33
P/E (Forward)17.81
PEG2.31
EV/EBITDA14.12
EV/Revenue6.90
P/S7.58
P/B4.04
EPS (TTM)27.06
EPS (Forward)31.77
52W Range
272.1290% of range609.35
52W High609.35 USD
52W Low272.12 USD
Profitability
Gross Margin87.92%
Oper. Margin41.69%
EBITDA Margin48.85%
Profit Margin41.94%
ROE18.81%
ROA16.94%
Growth
Revenue Growth-1.60%
Earnings Growth-12.20%
Cash Flow & Leverage
Operating CF1.56B USD
CapEx (TTM)526.00M USD
FCF Margin17.87%
FCF Yield2.31%
Net Debt-2.15B USD
Net Debt/EBITDA-1.39
Balance Sheet
Debt/Equity—
Current Ratio4.79
Quick Ratio4.12
Book Value/Sh139.98 USD
Cash/Share50.74 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateSep 23, 2009
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)665.23 USD
Target Range516.00 USD – 750.00 USD
# Analysts13
Ownership
Shares Out.42.45M
Float38.91M
Insiders2.04%
Institutions102.13%
Short Interest
Short Ratio4.3d
Short % Float6.75%
Short % Out.5.77%
Shares Short2.45M
Short (prev mo.)2.84M
Technical
SMA 50563.62 (+2.2%)
SMA 200474.70 (+21.4%)
Beta0.59
S&P 52W Chg28.31%
Avg Vol (30d)415.11K
Avg Vol (10d)414.40K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—